Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Shepherd

Showing results (571-580 of 726) with videos related to

Pageof 73
Sort By:
Pathogens and Global Health|March 31, 2015
Enrolment trends in a comprehensive HIV programme in rural north-central Nigeria: improved care indices, but declining quality of clinical data over timeMuktar H Aliyu, Meridith Blevins, Folasade Arinze, et al.
Leukemia & Lymphoma|January 17, 2020
Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and <i>BCL2</i> gene alterationsLina Chen, Kathrin Tyryshkin, Alison Moore, et al.
Springerplus|November 7, 2015
A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22Maureen Elizabeth Trudeau, Judith-Anne W Chapman, Baoqing Guo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancerMargot Burnell, Mark N Levine, Judith-Anne W Chapman, et al.
Plos One|September 24, 2013
Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in ZambiaMulindi H Mwanahamuntu, Vikrant V Sahasrabuddhe, Meridith Blevins, et al.
Breast Cancer Research : BCR|January 6, 2016
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 studyDennis C Sgroi, Judy-Anne W Chapman, T Badovinac-Crnjevic, et al.
The New England Journal of Medicine|July 18, 2003
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancerChristine M Ribic, Daniel J Sargent, Malcolm J Moore, et al.
Journal of the International AIDS Society|December 20, 2019
Temporal changes in ART initiation in adults with high CD4 counts in Latin America: a cohort studyBrenda E Crabtree-Ramírez, Yanink Caro-Vega, Pablo F Belaunzarán-Zamudio, et al.
Journal of Virology|May 25, 2007
A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivoJohn V Williams, Zhifeng Chen, Gabriella Cseke, et al.
Sexually Transmitted Infections|June 16, 2009
Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in ThailandA H Li, N Phanuphak, V V Sahasrabuddhe, et al.
Pageof 73

Showing results (571-580 of 726) with videos related to

Sort By:
Pageof 73
Pathogens and Global Health|March 31, 2015
Enrolment trends in a comprehensive HIV programme in rural north-central Nigeria: improved care indices, but declining quality of clinical data over timeMuktar H Aliyu, Meridith Blevins, Folasade Arinze, et al.
Leukemia & Lymphoma|January 17, 2020
Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and <i>BCL2</i> gene alterationsLina Chen, Kathrin Tyryshkin, Alison Moore, et al.
Springerplus|November 7, 2015
A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22Maureen Elizabeth Trudeau, Judith-Anne W Chapman, Baoqing Guo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancerMargot Burnell, Mark N Levine, Judith-Anne W Chapman, et al.
Plos One|September 24, 2013
Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in ZambiaMulindi H Mwanahamuntu, Vikrant V Sahasrabuddhe, Meridith Blevins, et al.
Breast Cancer Research : BCR|January 6, 2016
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 studyDennis C Sgroi, Judy-Anne W Chapman, T Badovinac-Crnjevic, et al.
The New England Journal of Medicine|July 18, 2003
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancerChristine M Ribic, Daniel J Sargent, Malcolm J Moore, et al.
Journal of the International AIDS Society|December 20, 2019
Temporal changes in ART initiation in adults with high CD4 counts in Latin America: a cohort studyBrenda E Crabtree-Ramírez, Yanink Caro-Vega, Pablo F Belaunzarán-Zamudio, et al.
Journal of Virology|May 25, 2007
A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivoJohn V Williams, Zhifeng Chen, Gabriella Cseke, et al.
Sexually Transmitted Infections|June 16, 2009
Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in ThailandA H Li, N Phanuphak, V V Sahasrabuddhe, et al.
Pageof 73